News Releases
July 31, 2008
PharmAthene Submits Response to DHHS Request for Proposals for Sparvax™ - a Recombinant Protective Antigen Vaccine.
download a pdf
July 10, 2008
PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel.
download a pdf
May 13, 2008
PharmAthene Reports First Quarter 2008 Financial Results.
download a pdf
May 6, 2008
PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008
download a pdf
April 9, 2008
PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease.
download a pdf
April 2, 2008
PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit.
download a pdf
March 31, 2008
PharmAthene Reports Year-End 2007 Financial Results.
download a pdf
March 26, 2008
Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia® Program.
download a pdf
March 20, 2008
PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business from Avecia.
download a pdf
March 13, 2008
PharmAthene to Host Year-End 2007 Earnings Conference Call and Webcast on Thursday, March 20, 2008.
download a pdf
March 10, 2008
PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference.
download a pdf
February 8, 2008
PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, PH.D. Senior Vice President of Operations.
download a pdf
February 6, 2008
PharmAthene to Present at the BIO CEO & Investor Conference 2008.
download a pdf
January 16, 2008
Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthene’s Legal Action in Breach of Contract Lawsuit Against SIGA.
download a pdf
January 8, 2008
PharmAthene and Medarex Announce FY 2008 U.S. Congressional Appropriation of up to $1.6 Million for Continued Development of Anthrax Therapeutic Valortim®.
download a pdf
November 13, 2007
PharmAthene Reports Third Quarter 2007 Financial Results
download a pdf
November 6, 2007
PharmAthene to Host Conference Call / Webcast Announcing its Third Quarter Financial Results on November 13, 2007 at 4:30 P.M. Eastern Time.
download a pdf
November 6, 2007
PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim®.
download a pdf
September 26, 2007
PharmAthene Awarded up to $13.9 Million NIH Contract to Develop Anthrax Anti-Toxin, Valortim® with Medarex.
download a pdf
September 24, 2007
PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services.
download a pdf
August 28, 2007
Delaware Court of Chancery Determines Validity of PharmAthene Merger.
download a pdf
August 13, 2007
Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court.
download a pdf
August 7, 2007
PharmAthene to Hold Investor Call Regarding Merger with HAQ.
download a pdf
August 7, 2007
PharmAthene Common Shares and Warrants to Resume Trading on the American Stock Exchange.
download a pdf
August 6, 2007
Healthcare Acquisition Corp. and PharmAthene, Inc. File Certificate of Merger to Complete Acquisition; Confirmation to be Sought from Delaware Court of Chancery Regarding Stockholder Vote.
download a pdf
August 3, 2007
Healthcare Acquisition Corp. and PharmAthene Receive Stockholder Approval for Their Merger.
download a pdf
July 31, 2007
Preliminary Data Add New Mechanistic Insights to Activity of Anthrax Anti-Toxin, Valortim®.
download a pdf
April 3, 2007
PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimer's Research.
download a pdf
March 29, 2007
Anthrax Monoclonal Antibody Valortim® Demonstrates Therapeutic Effect
in New Primate Model of Established Anthrax Infection
download a pdf
January 22, 2007
PharmAthene and Healthcare Acquisition Corp.
Announce Definitive Merger Agreement
download a pdf
January 8, 2007
PharmAthene Enhances Executive Leadership Team
and Appoints Christopher C. Camut Vice President
and Chief Financial Officer
download a pdf
November 6, 2006
PharmAthene Receives Tech Company of the Year
Award from Anne Arundel Tech Council
download a pdf
October 18, 2006
PharmAthene Awarded $1.7 Million NIH Grant for Protexia®
download a pdf
October 16, 2006
Medarex and PharmAthene Announce Phase I Results
of Anthrax Therapeutic Valortim®
download a pdf
October 11, 2006
PharmAthene and Medarex Announce $1 Million
Congressional Appropriation for Continued
Development of Anthrax Therapeutic Valortim®
download a pdf
September 25, 2006
PharmAthene Awarded $213 Million Department of
Defense Contract for Advanced Development of
Protexia®
download a pdf
June 12, 2006
PharmAthene Presents Data on Recombinant Human Butyrylcholinesterase
Program at Bioscience Review 2006
download a pdf
March 6, 2006
PharmAthene and Medarex Receive Orphan Drug Designation for Valortim® to Treat Anthrax Infection
download a pdf
January 10, 2006
PharmAthene and Medarex Receive $2.05 Million Congressional Appropriation for Continued Development of Valortim® for Prevention and Treatment of Anthrax Infection
download a pdf
January 9, 2006
PharmAthene and Medarex Receive FDA Fast Track Designation for Valortim® for Treatment of Anthrax Infection
download a pdf
December 14, 2005
Strategic Biodefense Platform Earns PharmAthene Anne Arundel Technology Council ‘Innovator of the Year’ Award
download a pdf
October 11, 2005
Fully Human Anti-Anthrax Antibody Enlists Immune System to Neutralize Anthrax Toxin in Preclinical Studies
download a pdf
August 8, 2005
PharmAthene and Medarex Announce Phase I Clinical Trial of Valortim®
download a pdf
March 10, 2005
PharmAthene Adds Premier Chemical Scavenger Franchise to its Leading Biological and Chemical Defense Portfolio
download a pdf
December 6, 2004
Medarex and PharmAthene Form Alliance to Develop and Commercialize Fully-Human Anti-Anthrax Monoclonal Antibody
download a pdf
October 12, 2004
PharmAthene Closes $50 Million in Series B Financing
download a pdf
February 19, 2004
Developer of Anthrax Anti-toxin Names New Management Team
download a pdf
